Terms: = Head and neck cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Treatment
45 results:
1. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
[TBL] [Abstract] [Full Text] [Related]
2. Economic evaluation of serplulimab plus chemotherapy as the first-line treatment of oesophageal squamous cell carcinoma in China.
Chen F; Long Y; Yang J; Zhong K; Liu B
BMJ Open; 2023 Dec; 13(12):e078924. PubMed ID: 38149425
[TBL] [Abstract] [Full Text] [Related]
3. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
Zhang L; San Valentin EMD; John TM; Jenq RR; Do KA; Hanna EY; Peterson CB; Reyes-Gibby CC
Cancer; 2024 Jan; 130(1):150-161. PubMed ID: 37688396
[TBL] [Abstract] [Full Text] [Related]
4. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma.
Deza S; Maroto J; Tellechea O; Orbegozo N; Merino J; Galofré JC; Alegre E; González Á
Clin Chim Acta; 2023 Aug; 548():117502. PubMed ID: 37516333
[TBL] [Abstract] [Full Text] [Related]
5. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
Yartsev VD; Atkova EL; Ekaterinchev MA
Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Value of Preoperative Controlling Nutritional Status in Hypopharyngeal cancer Patients Undergoing Surgery-Oriented Comprehensive treatment.
Ding T; Li W; Liu Y; Liu L; Dong Y
Ear Nose Throat J; 2023 Sep; 102(9):590-597. PubMed ID: 36593089
[TBL] [Abstract] [Full Text] [Related]
7. [Related factors and prognosis analysis of esophagorespiratory fistula after esophageal cancer surgery].
Sun P; Ren PW; Zhang JR; Zuo L; Yin YN; Shi JY; Zhu H; Yang S; Luo YX; Liu D
Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(44):3510-3514. PubMed ID: 36418248
[No Abstract] [Full Text] [Related]
8. Identification of benign and malignant thyroid nodules based on dynamic AI ultrasound intelligent auxiliary diagnosis system.
Wang B; Wan Z; Li C; Zhang M; Shi Y; Miao X; Jian Y; Luo Y; Yao J; Tian W
Front Endocrinol (Lausanne); 2022; 13():1018321. PubMed ID: 36237194
[TBL] [Abstract] [Full Text] [Related]
9. Long-Term Outcomes in head and neck Paragangliomas Managed with Intensity-Modulated Radiotherapy.
Rougier G; Rochand A; Bourdais R; Meillan N; Tankere F; Herman P; Riet F; Mazeron JJ; Burnichon N; Lussey-Lepoutre C; Jacob J; Simon JM; Maingon P; Feuvret L
Laryngoscope; 2023 Mar; 133(3):607-614. PubMed ID: 35638238
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab Plus Chemotherapy as First-Line treatment for Advanced Esophageal cancer: A Cost-Effectiveness Analysis.
Zhu Y; Liu K; Ding D; Zhou Y; Peng L
Adv Ther; 2022 Jun; 39(6):2614-2629. PubMed ID: 35394255
[TBL] [Abstract] [Full Text] [Related]
11. Identification and function of circular RNA hsa_circ_0071106: A novel biomarker for differentiation degree of esophageal squamous cell carcinoma.
Tang Y; Gao Z; Liu R
Pathol Res Pract; 2022 May; 233():153875. PubMed ID: 35390631
[TBL] [Abstract] [Full Text] [Related]
12. Meta-analysis of the efficacy and safety of thermal ablation for treating large benign thyroid nodules.
Ji X; Sun W; Lv C; Huang J; Zhang H
Clin Endocrinol (Oxf); 2022 Nov; 97(5):654-663. PubMed ID: 35170792
[TBL] [Abstract] [Full Text] [Related]
13. Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity cancer.
Chaukar D; Prabash K; Rane P; Patil VM; Thiagarajan S; Ghosh-Laskar S; Sharma S; Pai PS; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Vaish R; Noronha V; Patil A; Arya S; D'Cruz A
J Clin Oncol; 2022 Jan; 40(3):272-281. PubMed ID: 34871101
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma.
Liu Z; Williams M; Stewart J; Glisson BS; Fuller C; Roy-Chowdhuri S
Cancer Cytopathol; 2022 Feb; 130(2):110-119. PubMed ID: 34375025
[TBL] [Abstract] [Full Text] [Related]
15. Improved outcome prediction of oropharyngeal cancer by combining clinical and MRI features in machine learning models.
Bos P; van den Brekel MWM; Gouw ZAR; Al-Mamgani A; Taghavi M; Waktola S; Aerts HJWL; Castelijns JA; Beets-Tan RGH; Jasperse B
Eur J Radiol; 2021 Jun; 139():109701. PubMed ID: 33865064
[TBL] [Abstract] [Full Text] [Related]
16. Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study.
Mo Y; Zhang B; Pan Y; Qin Q; Ye Y; Li X; Huang L; Jiang W
Oral Oncol; 2021 May; 116():105258. PubMed ID: 33706048
[TBL] [Abstract] [Full Text] [Related]
17. Chronic opioid use after laryngeal cancer treatment.
Starr N; Oyler DR; Schadler A; Aouad RK
Head Neck; 2021 Apr; 43(4):1242-1251. PubMed ID: 33368718
[TBL] [Abstract] [Full Text] [Related]
18. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Huang J; Xu J; Chen Y; Zhuang W; Zhang Y; Chen Z; Chen J; Zhang H; Niu Z; Fan Q; Lin L; Gu K; Liu Y; Ba Y; Miao Z; Jiang X; Zeng M; Chen J; Fu Z; Gan L; Wang J; Zhan X; Liu T; Li Z; Shen L; Shu Y; Zhang T; Yang Q; Zou J;
Lancet Oncol; 2020 Jun; 21(6):832-842. PubMed ID: 32416073
[TBL] [Abstract] [Full Text] [Related]
19. Time and cost-analysis of virtual surgical planning for head and neck reconstruction: A matched pair analysis.
Mazzola F; Smithers F; Cheng K; Mukherjee P; Hubert Low TH; Ch'ng S; Palme CE; Clark JR
Oral Oncol; 2020 Jan; 100():104491. PubMed ID: 31794886
[TBL] [Abstract] [Full Text] [Related]
20. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract] [Full Text] [Related]
[Next]
